Biolinq Inc announced that it will receive $109,511,762 in a round of funding on September 2, 2021. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,050 KRW | +3.00% | -4.61% | +212.57% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
340 CAD | 0.00% | 0.00% | 615M | ||
129.3 USD | +0.56% | +1.11% | 6.87B | ||
1st Jan change | Capi. | |
---|---|---|
+212.57% | 280M | |
+75.69% | 12.57B | |
-28.44% | 6.88B | |
-1.83% | 6.06B | |
+10.01% | 5.02B | |
-18.23% | 4.73B | |
+15.57% | 4.03B | |
-22.78% | 3.76B | |
-21.51% | 2.91B | |
-1.24% | 1.97B |
- Stock Market
- Equities
- A294090 Stock
- News EOFLOW Co.,Ltd.
- Biolinq Inc announced that it expects to receive funding